The biotech stocks were hot on Thursday but some of them are taking huge blows today after a drug safety scare. Elan (ELN, $11.27, down $8.78) is down another 45% following Wednesday’s 14 point drop. The stock was at $34 on Tuesday when Elan released results of a clinical trialRead more

More